Results 21 to 30 of about 556,591 (206)

Influenza B presenting with bicytopenia in an adult – An unusual presentation and failure of antimicrobial stewardship by a practicing physician

open access: yesJournal of Family Medicine and Primary Care, 2020
Influenza is a very common cause of upper respiratory illness, rarely presented with bicytopenia, and is being wrongly treated with antimicrobials many-a-times.
Rajat Ranka   +2 more
doaj   +1 more source

Three-year COVID-19 and flu vaccinations among medical residents in a tertiary hospital in Italy: The threat of acceptance decline in seasonal campaigns

open access: yesHuman Vaccines & Immunotherapeutics, 2023
The COVID-19 vaccination campaign in Italy started in December 2020, and, due to the Omicron variant’s emergence, a second booster dose was recommended for high-risk individuals and healthcare workers from July 2022.
Flavia Beccia   +8 more
doaj   +1 more source

Socioeconomic costs of influenza complications in hospitalized children

open access: yesArchives of Medical Science, 2020
Introduction Influenza may be correlated with a high number of complications and generate high costs of treatment. The study aimed to estimate the socioeconomic significance of hospitalized influenza cases.
August Wrotek   +3 more
doaj   +1 more source

Vaccination of Patients with Comorbid Conditions against Meningococcal and Pneumococcal Disease and Influenza during the COVID-19 Pandemic – New Aspects

open access: yesЭпидемиология и вакцинопрофилактика, 2023
The review discusses and confirms the important role of vaccination of patients with comorbid conditions against pneumococcus, influenza and meningococcus in the context of the COVID-19 pandemic.
M. P. Kostinov   +2 more
doaj   +1 more source

Homeopathic medicines as a means of non-specific prophylaxis and therapy of influenza and acute respiratory diseases

open access: yesДетские инфекции (Москва), 2020
Many years of experience in the use of homeopathic medicines in the treatment and prevention of respiratory diseases has been accumulated in Russia; it testifies to the effectiveness of their use in pediatrics.Materials and methods.
O. V. Shamsheva
doaj   +1 more source

Adherence Population to Vaccination of Influenza: Survey Results

open access: yesЭпидемиология и вакцинопрофилактика, 2021
Influenza remains one of the most pressing medical and socio-economic problems . Vaccination is the most effective way to reduce the incidence and mortality of influenza and its complications.
T. A. Bayanova   +4 more
doaj   +1 more source

An Optimised Live Attenuated Influenza Vaccine Ferret Efficacy Model Successfully Translates H1N1 Clinical Data

open access: yesVaccines
Between 2013 and 2016, the A/H1N1pdm09 component of the live attenuated influenza vaccine (LAIV) produced instances of lower-than-expected vaccine effectiveness.
Katarzyna E. Schewe   +6 more
doaj   +1 more source

Human Influenza A(H7N9) Virus Infection Associated with Poultry Farm, Northeastern China

open access: yesEmerging Infectious Diseases, 2014
We report on a case of human infection with influenza A(H7N9) virus in Jilin Province in northeastern China. This case was associated with a poultry farm rather than a live bird market, which may point to a new focus for public health surveillance and ...
Ming Fan   +14 more
doaj   +1 more source

Vers une signature spatiale de la vulnérabilité épidémiologique en France : l'exemple de la grippe

open access: yesPhysio-Géo, 2010
The epidemiology of infectious diseases is in the heart of the concerns of numerous authorities of Public health. This theme was reactivated by the anguishes generated by the Severe Acute Respiratory Syndrome (SARS) or more recently by the fears of a flu-
Benjamin Lysianuk, Martine Tabeaud
doaj   +1 more source

Replication in human cells supersedes serum antigenic match for the in vivo efficacy of an A/H1N1pdm09 LAIV virus

open access: yesnpj Vaccines
For FluMist®/Fluenz live attenuated influenza vaccine (LAIV), efficient virus replication in human nasal epithelial cells (hNEC) is an important factor in vaccine effectiveness (VE).
Steffan Llewellyn   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy